Cargando…

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects

Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jean, Shio-Shin, Lee, Nan-Yao, Tang, Hung-Jen, Lu, Min-Chi, Ko, Wen-Chien, Hsueh, Po-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277544/ https://www.ncbi.nlm.nih.gov/pubmed/30538692 http://dx.doi.org/10.3389/fmicb.2018.02888

Ejemplares similares

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
por: Chen, Hsin-Yu, et al.
Publicado: (2021)

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
por: Sheu, Chau-Chyun, et al.
Publicado: (2019)

Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
por: Chen, Chi-Chung, et al.
Publicado: (2019)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Editorial: Carbapenem-resistant Enterobacteriaceae in the Asia Pacific and beyond, volume II
por: Tang, Yi-Wei
Publicado: (2023)

Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers
por: Thibodeau, Evangeline, et al.
Publicado: (2014)

Characteristics of Carbapenem-Resistant Enterobacteriaceae in Ready-to-Eat Vegetables in China
por: Liu, Bao-Tao, et al.
Publicado: (2018)

ChromID(®) CARBA Agar Fails to Detect Carbapenem-Resistant Enterobacteriaceae With Slightly Reduced Susceptibility to Carbapenems
por: Pauly, Natalie, et al.
Publicado: (2020)

Definitive Cefazolin Treatment for Community-Onset Enterobacteriaceae Bacteremia Based on the Contemporary CLSI Breakpoint: Clinical Experience of a Medical Center in Southern Taiwan
por: Lee, Ching-Chi, et al.
Publicado: (2019)

The Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Carrying the mcr-1 Gene
por: Chen, Chih-Wei, et al.
Publicado: (2019)

Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates
por: Tang, Hung-Jen, et al.
Publicado: (2016)

Clostridium difficile Bacteremia, Taiwan1
por: Lee, Nan-Yao, et al.
Publicado: (2010)

In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China
por: Miao, Minhui, et al.
Publicado: (2019)

Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains
por: Salloum, Noor A., et al.
Publicado: (2015)

Identification of DHA-23, a novel plasmid-mediated and inducible AmpC beta-lactamase from Enterobacteriaceae in Northern Taiwan
por: Hsieh, Wen-Shyang, et al.
Publicado: (2015)

In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
por: Hu, Ya, et al.
Publicado: (2017)

Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses Resistance to Colistin, but Not to Carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae
por: Osei Sekyere, John, et al.
Publicado: (2017)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Characterization of Carbapenem-Resistant Enterobacteriaceae Cultured From Retail Meat Products, Patients, and Porcine Excrement in China
por: Feng, Jie, et al.
Publicado: (2021)

A retrospective study on molecular epidemiology trends of carbapenem resistant Enterobacteriaceae in a teaching hospital in Malaysia
por: Kong, Zhi Xian, et al.
Publicado: (2022)

Gut microbiota alterations in critically Ill patients with carbapenem-resistant Enterobacteriaceae colonization: A clinical analysis
por: Baek, Moon Seong, et al.
Publicado: (2023)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Molecular Evidence for Intra- and Inter-Farm Spread of Porcine mcr-1-Carrying Escherichia coli in Taiwan
por: Hsueh, Shun-Chung, et al.
Publicado: (2020)

Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
por: Liao, Chun-Hsing, et al.
Publicado: (2019)

In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
por: Jean, Shio-Shin, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan
por: Tseng, Sung-Pin, et al.
Publicado: (2009)

Concurrent Resistance to Carbapenem and Colistin Among Enterobacteriaceae Recovered From Human and Animal Sources in Nigeria Is Associated With Multiple Genetic Mechanisms
por: Ngbede, Emmanuel O., et al.
Publicado: (2021)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aopulfnb6kfn9apvbepc5qt0iq